Lumos Diagnostics Holdings Share Price and Company Fundamentals

Price

$1.075

Change

-0.005 (-0.463%)

52 week

0.66 - 1.5

Last traded: Today at 4:48 AM

Lumos Diagnostics Holdings Limited operates as an integrated developer and manufacturer of point-of-care (POC) diagnostic tests. The company develops and manufactures proprietary and in-licensed POC diagnostic tests. Its products include FebriDx, a test that differentiates between bacterial and viral respiratory infections; ViraDx, a combined COVID/Influenza test for acute respiratory infections; and CoviDx, an antigen test for COVID-19. The company also engages in the contract research and development services specialized in the innovation, development, commercialization, and manufacturing of point-of-care diagnostic solutions for clinical and consumer applications. It offers its products through distributors primarily in the North American and European markets. The company was founded in 2004 and is headquartered in Melbourne, Australia.

Key Metrics

PE ratio

PB ratio

Dividend yield

Beta

Market cap

Enterprise value

Company profile

Primary activities	Development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests.
Industry / Sector	Diagnostics & Research / Healthcare
Website	https://lumosdiagnostics.com
Mailing address	Level 4 96-100 Albert Road South Melbourne Melbourne VIC 3205 Australia
Phone / Fax	61 3 9692 7222 /
Share registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

Lumos Diagnostics Holdings does not pay dividends.

Company Executives

As of Jan 2022, following are the company executives and directors listed on Lumos Diagnostics Holdings.

Name	Title	Age	Total Pay
Mr. Samuel Lanyon	Exec. Chairman		321.33k
Dr. Robert P. Sambursky M.D.	CEO, Pres & Exec. Director		578.26k
Ms. Melanie Jaye Leydin B.Bus, C.A., CA	CFO & Company Sec.	48
Mr. Kurt Phinney	VP of Operations
Dr. Sacha Dopheide Ph.D.	Chief Technology Officer
Ms. Jennifer Christiansen	VP of Corp. Marketing & Communications
Ms. Jill Thompson	Sr. VP of Corp. Strategy & Devel.
Ms. Sarah Glubka	Sr. Director of HR
Dr. Jeffrey Bishop	Sr. VP R&D
Mr. Aaron Erlandson	Sr. VP of Fin.

Profitability and management effectiveness

Profit margin

-80.33%

Operating margin

-59.16%

Return on assets

-10.62%

Return on equity

-36.65%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Lumos Diagnostics Holdings is and its enterprise value is .

Companies similar to Lumos Diagnostics Holdings (LDX)

Lumos Diagnostics Holdings (ASX:LDX) Frequently Asked Questions

1. What is Lumos Diagnostics Holdings's Stock Symbol?

Lumos Diagnostics Holdings trades on ASX under the ticker symbol "LDX".

2. What is Lumos Diagnostics Holdings's stock price today?

One share of LDX stock can currently be purchased for approximately $1.075.

3. How can I contact Lumos Diagnostics Holdings?

Lumos Diagnostics Holdings's mailing address is Level 4 96-100 Albert Road South Melbourne Melbourne VIC 3205 Australia. The company can be reached via phone at 61 3 9692 7222.

4. What is Lumos Diagnostics Holdings's official website?

The official website of Lumos Diagnostics Holdings is https://lumosdiagnostics.com.

5. Which share registry manages Lumos Diagnostics Holdings's stock?

Lumos Diagnostics Holdings's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.